GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

Investing.com -- GSK plc (LSE:GSK) announced Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the indication of its RSV ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has announced that the US FDA approved Blujepa (gepotidacin), a new ...

The Non-Opioid Therapeutics Market is rapidly expanding due to increased demand for safer pain management Non-Opioid Therapeutics Market Non-Opioid Therapeutics Market Dublin, Dec. 11, 2025 (GLOBE ...

DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...

Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...

Spotlight 5's Sarah Carnes spoke with Dr. Luis Romano about why adults over 50 should speak to their pharmacist about getting the shingles vaccine this holiday season.